Literature DB >> 2050589

Bactericidal effects of amoxycillin/clavulanic acid against a Legionella pneumophila pneumonia in the weanling rat.

G M Smith1, K H Abbott, M J Wilkinson, A S Beale, R Sutherland.   

Abstract

Amoxycillin/clavulanic acid and clavulanic acid have been previously reported to demonstrate bactericidal activity in tissue culture studies against intracellular Legionella pneumophila. A rat model of legionellosis was therefore developed for the purpose of assessing the efficacy of these agents against L. pneumophila in vivo. Therapy by the subcutaneous route was started 12 h after infection when the majority of the bacteria observed in lavage fluid were residing in alveolar macrophages. Treatment with amoxycillin was ineffective in reducing the bacterial counts of L. pneumophila in lung homogenates whereas amoxycillin/clavulanic acid displayed bactericidal effects of the same order as the control antibiotic, erythromycin. Further in-vivo studies are planned to assess the clinical relevance of these findings.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2050589     DOI: 10.1093/jac/27.1.127

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  5 in total

Review 1.  Treatment of Legionnaires' disease.

Authors:  Guy W Amsden
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Bactericidal effects of ticarcillin-clavulanic acid against Legionella pneumophila pneumonia in immunocompromised weanling rats.

Authors:  G M Smith; K H Abbott; M J Wilkinson; A S Beale; R Sutherland
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

3.  Fatal Legionella pneumophila pneumonia: treatment failure despite early sequential oral-parenteral amoxicillin-clavulanic acid therapy.

Authors:  P Hohl; U Buser; R Frei
Journal:  Infection       Date:  1992 Mar-Apr       Impact factor: 3.553

4.  In vitro extracellular and intracellular activities of clavulanic acid and those of piperacillin and ceftriaxone alone and in combination with tazobactam against clinical isolates of Legionella species.

Authors:  P H Edelstein; M A Edelstein
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

5.  Comparative activities of piperacillin and tazobactam against clinical isolates of Legionella spp.

Authors:  L A Collins; C B Wennersten; M J Ferraro; R C Moellering; G M Eliopoulos
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.